TI
SWTX

Trexquant Investment’s SpringWorks Therapeutics SWTX Stock Holding History

Trexquant Investment’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-49,843
Closed -$1.28M – 1796
2023
Q1 		$1.28M Buy
49,843
+12,948
+35% +$378K 0.04% 628
2022
Q4 		$960K Sell
36,895
-6,480
-15% -$160K 0.03% 662
2022
Q3 		$1.24M Sell
43,375
-44,972
-51% -$1.29M 0.04% 470
2022
Q2 		$2.17M Buy
+88,347
New +$3.23M 0.1% 244
2020
Q4 		– Sell
-7,274
Closed -$347K – 1470
2020
Q3 		$347K Buy
+7,274
New +$310K 0.02% 863

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Trexquant Investment's SWTX Position: Q2 2023 in Review

Trexquant Investment sold out of SpringWorks Therapeutics (SWTX) in Q2 2023, closing a stake of 49,843 shares — an estimated $1.28M sold.

Trexquant Investment first reported a position in SWTX in Q3 2020 and held it in 5 quarters. The position peaked at $2.17M in Q2 2022. 141 funds tracked by Wall St. Rank hold SWTX as of Q2 2023.

  • Trexquant Investment reported no remaining SpringWorks Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Trexquant Investment sold 49,843 SpringWorks Therapeutics shares in Q2 2023, an estimated $1.28M.
  • Trexquant Investment first reported a position in SpringWorks Therapeutics in Q3 2020 and held it in 5 quarters.
  • Trexquant Investment's SpringWorks Therapeutics position peaked at $2.17M in Q2 2022.
  • 141 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2023.

Based on Trexquant Investment's 13F filing for Q2 2023, filed 11 Aug 2023.